Gaffin David Joseph sold $110K of ALKS
Gaffin David Joseph (EVP, CLO, Alkermes, Inc.) sold 2,034 shares of Alkermes plc. (ALKS) at $54.03 ($0.11M total) on 2026-07-06 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The newest disclosed fact is the same-day open-market sale of 2,034 shares by an EVP at a stated price, under a pre-arranged 10b5-1 plan.
Market read
Traders may note the insider sale for sentiment monitoring, but there is no new fundamental information to drive a directional trade.
What to watch
The article lacks context on total planned sales, prior insider activity cadence, and whether the sale was part of a larger scheduled program; without that, signal strength is limited.
Background
This is a SEC Form 4 insider transaction filed via EDGAR for Alkermes plc (ALKS).
Ticker impact
Alkermes EVP David Joseph Gaffin filed a Form 4 selling 2,034 shares at $54.03 on 2026-07-06 under a 10b5-1 plan.
Low likelihood of sustained price impact; any reaction is likely muted and short-lived.
The filing is an open-market sale by an officer, explicitly under a pre-arranged 10b5-1 plan, with no accompanying operational, financial, or regulatory news disclosed.
Market effects
No clear read-across to the biotech/pharma sector because the disclosure is a planned insider transaction without new company fundamentals.
Minimal; this is a single-company insider sale with no broader market linkage stated.
Low; no international deal, regulator action, or supply-chain event is mentioned.
Counterpoint
Even with a 10b5-1 plan, repeated insider selling can still be watched as a sentiment check, especially if it coincides with other negative signals not present here.
Key entities
- issuerAlkermes plc
Subject of the Form 4 insider transaction; EVP David Joseph Gaffin sold shares under a 10b5-1 plan.
- insiderDavid Joseph Gaffin
EVP, CLO at Alkermes; reported open-market sale of 2,034 shares at $54.03.
